+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Capsid Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Capsid Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
MCL1 Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

MCL1 Protein Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Porphyria - Pipeline Insight, 2025 - Product Thumbnail Image

Porphyria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Gallbladder Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Gallbladder Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Africa Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Africa Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • January 2023
  • 78 Pages
  • Africa
From
Healthcare Services Market Report 2026 - Product Thumbnail Image

Healthcare Services Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator